BIOANALYTICAL SYS INC's ticker is BASI and the CUSIP is 09058M103. A total of 19 filers reported holding BIOANALYTICAL SYS INC in Q1 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $377,000 | +158.2% | 30,701 | -0.1% | 0.00% | – |
| Q3 2020 | $146,000 | +5.0% | 30,722 | +11.1% | 0.00% | – |
| Q2 2020 | $139,000 | +531.8% | 27,654 | +305.2% | 0.00% | – |
| Q1 2020 | $22,000 | -29.0% | 6,824 | +9.1% | 0.00% | – |
| Q4 2019 | $31,000 | +40.9% | 6,254 | +2.1% | 0.00% | – |
| Q3 2019 | $22,000 | +100.0% | 6,125 | +7.2% | 0.00% | – |
| Q2 2019 | $11,000 | 0.0% | 5,712 | +10.9% | 0.00% | – |
| Q1 2019 | $11,000 | +83.3% | 5,149 | +9.9% | 0.00% | – |
| Q4 2018 | $6,000 | -14.3% | 4,684 | +14.0% | 0.00% | – |
| Q3 2018 | $7,000 | 0.0% | 4,107 | +4.0% | 0.00% | – |
| Q2 2018 | $7,000 | +16.7% | 3,950 | +9.9% | 0.00% | – |
| Q1 2018 | $6,000 | -25.0% | 3,594 | +4.9% | 0.00% | – |
| Q4 2017 | $8,000 | +33.3% | 3,426 | +7.4% | 0.00% | – |
| Q3 2017 | $6,000 | +20.0% | 3,190 | +14.3% | 0.00% | – |
| Q2 2017 | $5,000 | +66.7% | 2,791 | +22.3% | 0.00% | – |
| Q1 2017 | $3,000 | – | 2,283 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HealthInvest Partners AB | 320,234 | $650,000 | 0.45% |
| Kessler Investment Group, LLC | 42,841 | $87,000 | 0.15% |
| NORTH STAR ASSET MANAGEMENT INC | 20,000 | $41,000 | 0.01% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3 | $0 | 0.00% |
| UBS Group AG | 5,118 | $10,000 | 0.00% |
| DIMENSIONAL FUND ADVISORS LP | 54,038 | $110,000 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 100 | $203,000 | 0.00% |
| STATE STREET CORP | 10,200 | $20,000 | 0.00% |
| MORGAN STANLEY | 14 | $0 | 0.00% |
| BANK OF MONTREAL /CAN/ | 230 | $0 | 0.00% |